WP
Waycross Partners Portfolio holdings
AUM
$1.06B
This Quarter Return
+10.5%
1 Year Return
+18.76%
3 Year Return
+112.27%
5 Year Return
–
10 Year Return
–
AUM
$461M
AUM Growth
+$461M
(+34%)
Cap. Flow
+$79.1M
Cap. Flow
% of AUM
17.17%
Top 10 Holdings %
Top 10 Hldgs %
41.02%
Holding
99
New
12
Increased
35
Reduced
15
Closed
4
Top Buys
| 1 |
Target
TGT
|
$11.8M |
| 2 |
Humana
HUM
|
$10.6M |
| 3 |
Thermo Fisher Scientific
TMO
|
$10.3M |
| 4 |
Apple
AAPL
|
$6.02M |
| 5 |
Microsoft
MSFT
|
$5.19M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$11.2M |
| 2 |
Adobe
ADBE
|
$7.77M |
| 3 |
Elanco Animal Health
ELAN
|
$2.14M |
| 4 |
Marvell Technology
MRVL
|
$1.62M |
| 5 |
Carlisle Companies
CSL
|
$1.54M |
Sector Composition
| 1 | Technology | 26.06% |
| 2 | Healthcare | 20.03% |
| 3 | Consumer Discretionary | 15.74% |
| 4 | Financials | 15% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
BioMarin Pharmaceuticals
BMRN
$11.2B
| $607K | 0.13% | 7,000 | – | – |
|
77
Amgen
AMGN
$155B
| $577K | 0.13% | 2,600 | – | – |
|
78
M&T Bank
MTB
$31.5B
| $563K | 0.12% | 4,550 +2,300 | +102% | +$285K |
|
79
Nike
NKE
$114B
| $519K | 0.11% | 4,700 | – | – |
|
80
Global Payments
GPN
$21.5B
| $517K | 0.11% | 5,250 +500 | +11% | +$49.3K |
|
81
Bank of New York Mellon
BK
$74.5B
| $512K | 0.11% | 11,500 +4,000 | +53% | +$178K |
|
82
Snowflake
SNOW
$79.6B
| $493K | 0.11% | 2,800 -300 | -10% | -$52.8K |
|
83
Starwood Property Trust
STWD
$7.44B
| $475K | 0.1% | +24,500 | New | +$475K |
|
84
Colgate-Palmolive
CL
$67.9B
| $462K | 0.1% | 6,000 | – | – |
|
85
Fiserv
FI
$75.1B
| $404K | 0.09% | 3,200 | – | – |
|
86
Kinder Morgan
KMI
$60B
| $344K | 0.07% | 20,000 +3,000 | +18% | +$51.7K |
|
87
lululemon athletica
LULU
$24.2B
| $341K | 0.07% | +900 | New | +$341K |
|
88
UBS Group
UBS
$128B
| $334K | 0.07% | +16,500 | New | +$334K |
|
89
State Street
STT
$32.6B
| $329K | 0.07% | +4,500 | New | +$329K |
|
90
RTX Corp
RTX
$212B
| $309K | 0.07% | 3,151 | – | – |
|
91
Bristol-Myers Squibb
BMY
$96B
| $291K | 0.06% | 4,557 | – | – |
|
92
Johnson & Johnson
JNJ
$427B
| $281K | 0.06% | 1,700 | – | – |
|
93
Truist Financial
TFC
$60.4B
| $273K | 0.06% | +9,000 | New | +$273K |
|
94
Northern Trust
NTRS
$25B
| $256K | 0.06% | +3,450 | New | +$256K |
|
95
Exxon Mobil
XOM
$487B
| $224K | 0.05% | 2,090 | – | – |
|
|
96
Elanco Animal Health
ELAN
$9.12B
| – | – | -228,149 | Closed | -$2.14M |
|
97
Halliburton
HAL
$19.4B
| – | – | -21,700 | Closed | -$687K |
|
98
Pfizer
PFE
$141B
| – | – | -5,245 | Closed | -$214K |
|
99
Atlassian
TEAM
$46.6B
| – | – | -2,850 | Closed | -$488K |
|